顯微鏡服務  製造商、經銷商、供應商

Qingdao combi medical and laboratory products Co., Ltd., is located in the beautiful coastal city - qingdao, covering a hundred acres, more than 200 employees, is a professional manufacturer of medical and laboratory instruments. Over years, combi has become a research and development, production, sales as one of the group of high-tech enterprises in the industry reputation. Company to "leading technology, unlimited service" for the purpose of quality management as the cornerstone, and the implementation of modern management, advanced technology mainstream, first-class technical force is committed to creating an internationally competitive brands.
Combi has passed ISO9001 quality system certification and the international alliance certification. Our products, covering medical devices, laboratory equipment and other industries in 120 categories, medical equipment, laboratory equipment and quality leader in the production and sales of similar products in China, exported to the international market, such as laboratory incubator, medical freezer, biological safety cabinet, freeze dryer, deep freezer, lab washing disinfection, ULT freezer, glassware washing disinfector, glassware washer and so on.
Combi brings together a group of equipment research and development and sales experience in technology and management experts, established in the country more than 100 distribution outlets, the company has product development, brand planning, quality management, customer service and marketing expertise, etc. And corporate management experience in the service centers established throughout the country.
Combi aim is: To provide full high-quality products, dedicated to providing professional services.

ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. In the past fiscal year, the ZEISS Group generated annual revenue totaling 6.3 billion euros in the four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets, and invested 13 percent of its revenue in research and development (as of 30 September 2020). ZEISS has a long tradition of similarly high expenditures for research and development, which also represent an investment in the future.
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.Over 32,000 employees in almost 50 countries work at around 30 production sites, 60 sales and service locations and 27 research and development facilities. The company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.